Sign in
4

Changes in Ownership

4D Molecular Therapeutics, Inc. Filed Acc 0001140361-23-023022

Chief Executive Officer gave 600,000 shares (gift)

  • Chief Executive Officer gave 600,000 shares (gift)

From the SEC's structured data for this filing

Trades in this filing

Kirn David · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Owned after D/I
2023-05-02 Gift : show line 1 in the form −600,000 1,259,153 D
2023-05-02 Gift : show line 2 in the form +600,000 600,000 I
Loading xslF345X04/form4.xml…